Adaptive Biotechnologies Corporation (1HM BE) stock market data APIs
€11.0199
-0.2(-1.8%)
as of September 15, 2025
Try our APIs with
free plan!
Adaptive Biotechnologies Corporation Financial Data Overview
Price chart is built with
Anychart
Prev. Close
11.0199
Open
10.824
High
11.2348
Low
10.6512
52 wk Range
3.597-11.575
Market Cap
3 337 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corporation data using free add-ons & libraries
Get Adaptive Biotechnologies Corporation Fundamental Data
Adaptive Biotechnologies Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Adaptive Biotechnologies Corporation End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corporation News
New
Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ev...
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
Shares of Adaptive Biotechnologies (ADPT) have been strong performers lately, with the stock up 30% over the past month. The stock hit a new 52-week high of $13.52 in the previous session. Adaptive Bi...
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Adaptive Biotechnologies SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Adaptive Biotechnologies (ADPT) is a stock that can certainly grab the attention of ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
